Why the study?
To review important factors in perioperative opioid use, multimodal analgesia, and responsible opioid stewardship in gynecologic oncology.
This review outlines actionable recommendations for perioperative pain management, multimodal analgesia, and responsible opioid stewardship in gynecologic oncology.
Answers are grounded in this paper and cite their sources.
May inform individualized perioperative opioid strategies in gynecologic oncology; leaves open validation of machine learning tools.
This mini-review discusses important factors in opioid use in gynecologic oncology in the perioperative setting. Evidence-based prescribing guidelines, multimodal analgesia strategies, and individualized care in patients with a history of opioid use are discussed. Opioid tapering and its potential risks are also discussed. Additionally, we touch on machine learning in optimizing analgesia. By bridging evidence-based practices and advancements, this review outlines actionable recommendations to maximize patient care and facilitate responsible opioid stewardship in gynecologic oncology.
No takes yet. Share an insight, caveat, or question.
Boitano et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: